نتائج البحث - "Moochhala, Shabbir H."

المصدر: Metry , E L , Garrelfs , S F , Deesker , L J , Acquaviva , C , D'Ambrosio , V , Bacchetta , J , Beck , B B , Cochat , P , Collard , L , Hogan , J , Ferraro , P M , Franssen , C F M , Harambat , J , Hulton , S-A , Lipkin , G W , Mandrile , G , Martin-Higueras , C , Mohebbi , N , Moochhala , S H , Neuhaus , T J , Prikhodina , L , Salido , E , Topaloglu ....

وصف الملف: application/pdf

العلاقة: https://research.rug.nl/en/publications/6954ce6b-5145-41fe-99e4-165d26ad95cfTest

الإتاحة: https://doi.org/10.1016/j.ekir.2023.07.025Test
https://hdl.handle.net/11370/6954ce6b-5145-41fe-99e4-165d26ad95cfTest
https://research.rug.nl/en/publications/6954ce6b-5145-41fe-99e4-165d26ad95cfTest
https://pure.rug.nl/ws/files/821729021/1-s2.0-S2468024923014043-main.pdfTest

View record in BASE

4

دورية أكاديمية

Rare variants in the sodium-dependent phosphate transporter gene SLC34A3 explain missing heritability of urinary stone disease

المؤلفون: Sadeghi-Alavijeh, Omid, Chan, Melanie My, Moochhala, Shabbir H, Genomics England Research, Consortium, Howles, Sarah, Gale, Daniel P, Böckenhauer, Detlef

المصدر: Kidney International , 104 (5) pp. 975-984. (2023)

مصطلحات موضوعية: genetics, genomics, polygenic risk score, urinary stone disease

وصف الملف: text

العلاقة: https://discovery.ucl.ac.uk/id/eprint/10173503/1/Gale_1-s2.0-S0085253823004738-main.pdfTest; https://discovery.ucl.ac.uk/id/eprint/10173503Test/

الإتاحة: https://discovery.ucl.ac.uk/id/eprint/10173503/1/Gale_1-s2.0-S0085253823004738-main.pdfTest
https://discovery.ucl.ac.uk/id/eprint/10173503Test/

View record in BASE

5

دورية أكاديمية

PHYOX2: a pivotal randomized study of nedosiran in primary hyperoxaluria type 1 or 2

المؤلفون: Baum, Michelle A., Langman, Craig B., Cochat, Pierre, Lieske, John, Moochhala, Shabbir H., Hamamoto, Shuzo, Ariceta Iraola, Gema

المساهمون: Institut Català de la Salut, Baum MA Division of Nephrology, Boston Children’s Hospital, Boston, Massachusetts, USA. Langman C Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. Cochat P Reference Centre for Rare Renal Diseases, Hôpital Femme Mère Enfant, Lyon, France. Lieske JC Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA. Moochhala SH UCL Department of Renal Medicine, Royal Free Hospital, London, UK. Hamamoto S Department of Nephro-urology, Nagoya City University, Nagoya, Japan. Ariceta G Servei de Nefrologia Pediàtrica, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Ronyons - Malalties - Tractament, Malalties congènites - Tractament, Expressió gènica, DISEASES::Congenital, Hereditary, and Neonatal Diseases and Abnormalities::Genetic Diseases, Inborn::Metabolism, Inborn Errors::Carbohydrate Metabolism, Inborn Errors::Hyperoxaluria, Primary, Other subheadings::Other subheadings::Other subheadings::/drug therapy, PHENOMENA AND PROCESSES::Genetic Phenomena::Gene Expression, DISEASES::Male Urogenital Diseases::Urologic Diseases::Kidney Diseases, ENFERMEDADES::enfermedades y anomalías neonatales congénitas y hereditarias::enfermedades genéticas congénitas::alteraciones congénitas del metabolismo::trastornos congénitos del metabolismo de los carbohidratos::hiperoxaluria primaria, Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia, FENÓMENOS Y PROCESOS::fenómenos genéticos::expresión génica, ENFERMEDADES::enfermedades urogenitales masculinas::enfermedades urológicas::enfermedades renales

وصف الملف: application/pdf

العلاقة: Kidney International;103(1); https://doi.org/10.1016/j.kint.2022.07.025Test; Baum MA, Langman C, Cochat P, Lieske JC, Moochhala SH, Hamamoto S, et al. PHYOX2: A Pivotal Randomized Study of Nedosiran in Primary Hyperoxaluria Type 1 or 2. Kidney Int. 2023 Jan;103(1):207-17.; https://hdl.handle.net/11351/8992Test

الإتاحة: https://doi.org/10.1016/j.kint.2022.07.025Test
https://hdl.handle.net/11351/8992Test

View record in BASE

6

دورية أكاديمية

ePHex: a phase 3, double-blind, placebo-controlled, randomized study to evaluate long-term efficacy and safety of Oxalobacter formigenes in patients with primary hyperoxaluria

المؤلفون: Collard, Laure, Moochhala, Shabbir H., Gould, Edward, Boussetta, Abir, Fraga Rodriguez, Gloria Mª, ABROUG, Saoussen, Ariceta Iraola, Gema

المساهمون: Institut Català de la Salut, Ariceta G Vall d’Hebron Hospital Universitari, Barcelona, Spain. Collard L Centre Hospitalier Umniversitaire de Liege, Liege, Belgium. Abroug S Hôpital Universitaire Sahloul, Sousse, Tunisia. Moochhala SH Royal Free Hospital, London, UK. Gould E Vanderbilt University Hospital, Nashville, USA. Boussetta A Charles Nicolle University Hospital, Tunis, Tunisia. Fraga G Vall d’Hebron Hospital Universitari, Barcelona, Spain. Hospital Sant Pau, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Malalties congènites - Tractament, Bacteris anaerobis, Ronyons - Malalties - Tractament, ORGANISMS::Bacteria::Gram-Negative Bacteria::Gram-Negative Anaerobic Bacteria::Gram-Negative Anaerobic Straight, Curved, and Helical Rods::Oxalobacter formigenes, DISEASES::Congenital, Hereditary, and Neonatal Diseases and Abnormalities::Genetic Diseases, Inborn::Metabolism, Inborn Errors::Carbohydrate Metabolism, Inborn Errors::Hyperoxaluria, Primary, Other subheadings::Other subheadings::/therapy, ORGANISMOS::Bacteria::bacterias gramnegativas::bacterias anaerobias gramnegativas::bacilos anaerobios gramnegativos, rectos, curvos y espirales::Oxalobacter formigenes, ENFERMEDADES::enfermedades y anomalías neonatales congénitas y hereditarias::enfermedades genéticas congénitas::alteraciones congénitas del metabolismo::trastornos congénitos del metabolismo de los carbohidratos::hiperoxaluria primaria, Otros calificadores::Otros calificadores::/terapia

وصف الملف: application/pdf

العلاقة: Pediatric Nephrology;38(2); https://doi.org/10.1007/s00467-022-05591-5Test; Ariceta G, Collard L, Abroug S, Moochhala SH, Gould E, Boussetta A, et al. ePHex: a phase 3, double-blind, placebo-controlled, randomized study to evaluate long-term efficacy and safety of Oxalobacter formigenes in patients with primary hyperoxaluria. Pediatr Nephrol. 2023 Feb;38(2):403–15.; https://hdl.handle.net/11351/8962Test; 000794091100003

الإتاحة: https://doi.org/10.1007/s00467-022-05591-5Test
https://hdl.handle.net/11351/8962Test

View record in BASE

7

دورية أكاديمية

Long-Term Transplantation Outcomes in Patients With Primary Hyperoxaluria Type 1 Included in the European Hyperoxaluria Consortium (OxalEurope) Registry.

المصدر: Kidney International Reports, 7 (2), 210-220 (2022-02)

مصطلحات موضوعية: combined liver-kidney transplantation, graft survival, primary hyperoxaluria, sequential liver-kidney transplantation, Human health sciences, Urology & nephrology, Pediatrics, Sciences de la santé humaine, Urologie & néphrologie, Pédiatrie

العلاقة: urn:issn:2468-0249

الوصول الحر: https://orbi.uliege.be/handle/2268/300063Test

View record in ORBi

8

دورية أكاديمية

Long-Term Transplantation Outcomes in Patients With Primary Hyperoxaluria Type 1 Included in the European Hyperoxaluria Consortium (OxalEurope) Registry

المصدر: OxalEurope Consortium , Metry , E L , Garrelfs , S F , Peters-Sengers , H , Hulton , S A , Acquaviva , C , Bacchetta , J , Beck , B B , Collard , L , Deschênes , G , Franssen , C , Kemper , M J , Lipkin , G W , Mandrile , G , Mohebbi , N , Moochhala , S H , Oosterveld , M J S , Prikhodina , L , Hoppe , B , Cochat , P & Groothoff , J W 2022 , ' Long-Term Transplantation Outcomes in ....

مصطلحات موضوعية: combined liver-kidney transplantation, graft survival, primary hyperoxaluria, sequential liver-kidney transplantation, LIVER-KIDNEY TRANSPLANTATION, GENOTYPE-PHENOTYPE CORRELATION, SYSTEMIC OXALOSIS, SEQUENTIAL LIVER, AGXT MUTATION, LIVING DONOR, CHILDREN, PYRIDOXINE, DIAGNOSIS, STRATEGY